Acquired resistance to temsirolimus in human renal cell carcinoma cells is mediated by the constitutive activation of signal transduction pathways through mTORC2
Kenichi Harada(Kanazawa University Hospital), M. Fujisawa(Kobe University)
Cited by 39
Related Papers
Clusterin inhibition using OGX-011 synergistically enhances antitumour activity of sorafenib in a human renal cell carcinoma model
|British Journal of Cancer|2012|42
The cyclin‑dependent kinase pathway involving CDK1 is a potential therapeutic target for cholangiocarcinoma
|Oncology Reports|2019|24
Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells
|British Journal of Cancer|2009|16
Monitoring of Heat Shock Response and Phenotypic Changes in Hepatocellular Carcinoma After Heat Treatment
|Anticancer Research|2019|10